What is the best medication for restless legs syndrome at night?

Best Medication for Restless Legs Syndrome at Night

For adults with restless legs syndrome (RLS), gabapentin or pregabalin are the best first-line medications, with gabapentin being the strongest recommendation based on the most recent 2025 American Academy of Sleep Medicine guidelines 1.

Treatment Algorithm

Step 1: Check Iron Status First

Before starting any medication, check ferritin and transferrin saturation levels. If ferritin is <75 ng/mL or transferrin saturation is <20%, iron replacement is indicated 1:

• IV ferric carboxymaltose (strong recommendation, moderate certainty) - most effective iron formulation 1
• Oral ferrous sulfate with vitamin C if IV therapy unavailable (conditional recommendation) 1
• Target ferritin >100 ng/mL 2

Step 2: First-Line Pharmacotherapy (if iron adequate)

Alpha-2-delta calcium channel ligands are now first-line:

• Gabapentin - AASM strong recommendation, moderate certainty of evidence 1
• Pregabalin - AASM strong recommendation, moderate certainty of evidence 1

These medications have replaced dopamine agonists as first-line therapy due to the significant risk of augmentation (paradoxical worsening of symptoms) with long-term dopaminergic use 3, 2.

Step 3: Second-Line Options (if first-line fails)

• Extended-release oxycodone or other opioids - conditional recommendation for refractory cases 1
• Dipyridamole - conditional recommendation, though not globally supported 1, 4

Step 4: What NOT to Use as Standard Treatment

The 2025 guidelines represent a major paradigm shift - dopamine agonists (pramipexole, ropinirole, rotigotine) are now suggested AGAINST for standard use 1. This is a dramatic reversal from older guidelines that recommended these as first-line 5.

Key reasons for downgrading dopamine agonists:

• High risk of augmentation (worsening symptoms over time)
• Should only be considered for short-term use in patients who prioritize immediate symptom relief over long-term adverse effects 1
• If used at all, keep doses minimal and duration brief 2

Strongly avoid:

• Cabergoline - strong recommendation AGAINST (cardiac valvulopathy risk) 1
• Clonazepam, valproic acid, carbamazepine, bupropion - all recommended against 1

Special Populations

End-stage renal disease (ESRD) patients:

• Gabapentin remains an option (conditional recommendation) 1
• IV iron sucrose if ferritin <200 ng/mL and transferrin saturation <20% 1
• Vitamin C supplementation 1

Critical Pitfalls to Avoid

1. Don't start dopamine agonists as first-line - this is outdated practice despite their historical use 3, 2
2. Don't skip iron assessment - iron deficiency is a reversible cause and treating it may eliminate need for other medications 1, 2
3. Don't use levodopa for chronic treatment - very high augmentation risk 1
4. Watch for augmentation - if symptoms worsen, occur earlier in day, or spread to other body parts on dopaminergic therapy, this is augmentation requiring medication change 6, 3

Practical Implementation

Start with gabapentin as it has the strongest evidence base with moderate certainty 1. Pregabalin is equally recommended but may have different availability or cost considerations depending on location 4. Both provide 24-hour coverage, which is important since RLS symptoms can occur throughout the day in severe cases 7.

The evidence strongly supports this approach prioritizing long-term quality of life and avoiding the morbidity associated with augmentation, which can make RLS significantly worse than the original untreated condition 3, 2.